Changes in the diagnosis and management of acute aortic syndrome and associated mortality in the last 20 years.

Acute aortic syndrome Aortic dissection Aortic surgery Cirugía de aorta Disección de aorta Endovascular treatment Imaging techniques Prognosis Pronóstico Síndrome aórtico agudo Tratamiento endovascular Técnicas de imagen

Journal

Revista espanola de cardiologia (English ed.)
ISSN: 1885-5857
Titre abrégé: Rev Esp Cardiol (Engl Ed)
Pays: Spain
ID NLM: 101587954

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 09 10 2019
accepted: 12 02 2020
pubmed: 6 6 2020
medline: 23 4 2021
entrez: 6 6 2020
Statut: ppublish

Résumé

Mortality is high in acute aortic syndrome (AAS), which therefore requires early treatment. This study aimed to analyze changes in the diagnosis and treatment of AAS over 20 years at our center. From 1999 to 2018, 451 patients diagnosed with AAS (336 men; mean age, 60.9±12.4 years) were prospectively included (270 type A and 181 type B). Clinical variables, diagnosis, treatment, and in-hospital complications were analyzed. The use of computed tomography (CT) as the first-line diagnostic technique increased from 62.8% to 94.2% (P <.001). Surgical treatment of type A AAS rose from 67.4% to 82.5% (P=.09). Mortality from type A AAS decreased significantly from 53.1% to 26.3% (P <.001) as a result of the fall in mortality from surgical treatment (from 45.4% to 17.0%; P <.001). The use of medical treatment alone for type B AAS decreased from 91.8% to 61.7% (P <.001) due to the greater use of endovascular treatment. Mortality from type B AAS showed no significant reduction (16.2% to 10.6%; P=.15). The diagnosis and treatment of AAS has changed substantially in the last 2 decades. CT has become the first-line diagnostic technique for AAS. In type A AAS, mortality has fallen significantly due to improvements in the results of surgical treatment. In type B AAS, the use of medical treatment alone has decreased due to the expansion of endovascular treatment, although in-hospital mortality has not decreased significantly.

Identifiants

pubmed: 32499017
pii: S1885-5857(20)30180-8
doi: 10.1016/j.rec.2020.02.015
pii:
doi:

Types de publication

Journal Article

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

257-262

Informations de copyright

Copyright © 2020 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

Arturo Evangelista (A)

Servicio de Cardiología, Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron (VHIR), Barcelona, CIBER-CV, Spain. Electronic address: arturevangelistamasip@gmail.com.

José A Barrabés (JA)

Servicio de Cardiología, Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron (VHIR), Barcelona, CIBER-CV, Spain.

Rosa-María Lidón (RM)

Servicio de Cardiología, Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron (VHIR), Barcelona, CIBER-CV, Spain.

Rafael Rodríguez-Lecoq (R)

Servicio de Cirugía Cardiaca, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Jordi Maeso (J)

Servicio de Cirugía Vascular, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Sergi Bellmunt (S)

Servicio de Cirugía Vascular, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Ángela López-Sainz (Á)

Servicio de Cardiología, Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron (VHIR), Barcelona, CIBER-CV, Spain.

Carlos Sureda (C)

Servicio de Cirugía Cardiaca, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Gisela Teixidó-Tura (G)

Servicio de Cardiología, Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron (VHIR), Barcelona, CIBER-CV, Spain.

Teresa González-Alujas (T)

Servicio de Cardiología, Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron (VHIR), Barcelona, CIBER-CV, Spain.

Hug Cuellar (H)

Servicio de Radiología, IDI, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Augusto Sao-Aviles (A)

Servicio de Cardiología, Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron (VHIR), Barcelona, CIBER-CV, Spain.

David García-Dorado (D)

Servicio de Cardiología, Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron (VHIR), Barcelona, CIBER-CV, Spain.

Ignacio Ferreira-González (I)

Servicio de Cardiología, Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron (VHIR), Barcelona, CIBER-CV, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Spain.

José Rodríguez-Palomares (J)

Servicio de Cardiología, Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron (VHIR), Barcelona, CIBER-CV, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH